Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency.

Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 Jul 2024

Yoldas Celik Merve, Canda Ebru, Yazici Havva, Erdem Fehime, Yuksel Yanbolu Ayse, Atik Altinok Yasemin, Pariltay Erhan, Akin Haluk, Kalkan Ucar Sema, Coker Mahmut

Abstract excerpt

BACKGROUND AND AIM: APO CII, one of several cofactors which regulate lipoprotein lipase enzyme activity, plays an essential role in lipid metabolism. Deficiency of APO CII is an ultra-rare autosomal recessive cause of familial chylomicronemia syndrome. We present the long-term clinical outcomes of 12 children with APO CII deficiency. METHODS AND RESULTS: The data of children with genetically confirmed APO CII...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Apolipoprotein C-II

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biomarkers

Share to Diet, Fat-Restricted

Share to Hyperlipoproteinemia Type I

Share to Hypolipidemic Agents

Share to Treatment Outcome

Share to Triglycerides

Source

Identifiers

PMID: 38503616
DOI: 10.1016/j.numecd.2024.02.006

Genes

TG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency.PMID 38503616Read ↗

Clinical identification of familial chylomicronemia syndrome and novel therapeutic options.Semantic proximity Read ↗

Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.Semantic proximity Read ↗

Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry.Semantic proximity Read ↗

Infantile extreme hypertriglyceridemia diagnosed as glycogen storage disease type Ia: A case report.Semantic proximity Read ↗

Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.Semantic proximity Read ↗

Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novelGPIHBP1mutationSemantic proximity Read ↗

Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.Semantic proximity Read ↗

Successful management of acute pancreatitis due to apolipoprotein C-II deficiency in a 37-day-old infant.Semantic proximity Read ↗

Comprehensive analysis of Chinese patients with non-LPL familial chylomicronemia syndrome: Genetic variants, dietary interventions, and clinical insights.Semantic proximity Read ↗

Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.Semantic proximity Read ↗

Case Studies in Pediatric Lipid Disorders and Their Management.Semantic proximity Read ↗

The familial chylomicronemia syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.